{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T17:25:08Z","timestamp":1790443508996,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,15]],"date-time":"2018-11-15T00:00:00Z","timestamp":1542240000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Legal Med"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1007\/s00414-018-1969-3","type":"journal-article","created":{"date-parts":[[2018,11,15]],"date-time":"2018-11-15T16:03:00Z","timestamp":1542297780000},"page":"133-142","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Case report: relevance of metabolite identification to detect new synthetic opioid intoxications illustrated by U-47700"],"prefix":"10.1007","volume":"133","author":[{"given":"Camille","family":"Richeval","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1111-4671","authenticated-orcid":false,"given":"Jean-Michel","family":"Gaulier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovic","family":"Romeuf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Allorge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvan","family":"Gaillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,15]]},"reference":[{"key":"1969_CR1","volume-title":"European Drug Report 2017: Trends and Developments","author":"EMCDDA","year":"2017","unstructured":"EMCDDA (2017) European Drug Report 2017: Trends and Developments. Publications Office of the European Union, Luxembourg"},{"key":"1969_CR2","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1097\/ADM.0000000000000324","volume":"11","author":"MP Prekupec","year":"2017","unstructured":"Prekupec MP, Mansky PA, Baumann MH (2017) Misuse of novel synthetic opioids: a deadly new trend. J Addict Med 11:256\u2013265. \n                    https:\/\/doi.org\/10.1097\/ADM.0000000000000324","journal-title":"J Addict Med"},{"issue":"1","key":"1969_CR3","doi-asserted-by":"publisher","first-page":"6338","DOI":"10.1038\/s41598-017-06778-9","volume":"7","author":"D Fabregat-Safont","year":"2017","unstructured":"Fabregat-Safont D, Carb\u00f3n X, Ventura M, Forn\u00eds I, Guillam\u00f3n E, Sancho JV, Hern\u00e1ndez F, Ib\u00e1\u00f1ez M (2017) Updating the list of known opioids through identification and characterization of the new opioid derivative 3,4-dichloro-N-(2-(diethylamino)cyclohexyl)-N-methylbenzamide (U-49900). Sci Rep 7(1):6338. \n                    https:\/\/doi.org\/10.1038\/s41598-017-06778-9","journal-title":"Sci Rep"},{"issue":"9","key":"1969_CR4","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1093\/jat\/bkw086","volume":"40","author":"AL Mohr","year":"2016","unstructured":"Mohr AL, Friscia M, Papsun D, Kacinko SL, Buzby D, Logan BK (2016) Analysis of novel synthetic opioids U-47700, U-50488 and furanyl fentanyl by LC-MS\/MS in postmortem casework. J Anal Toxicol 40(9):709\u2013717. \n                    https:\/\/doi.org\/10.1093\/jat\/bkw086","journal-title":"J Anal Toxicol"},{"issue":"4","key":"1969_CR5","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.jemermed.2017.05.034","volume":"53","author":"KA Rambaran","year":"2017","unstructured":"Rambaran KA, Fleming SW, An J, Burkhart S, Furmaga J, Kleinschmidt KC, Spiekerman AM, Alzghari SK (2017) U-47700: a clinical review of the literature. J Emerg Med 53(4):509\u2013519. \n                    https:\/\/doi.org\/10.1016\/j.jemermed.2017.05.034","journal-title":"J Emerg Med"},{"key":"1969_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jat\/bkx081","volume":"11","author":"TP Rohrig","year":"2017","unstructured":"Rohrig TP, Miller SA, Baird T (2017) U-47700: a not so new opioid. J Anal Toxicol 11:1\u20133. \n                    https:\/\/doi.org\/10.1093\/jat\/bkx081","journal-title":"J Anal Toxicol"},{"key":"1969_CR7","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1021\/jm00150a017","volume":"28","author":"BV Cheney","year":"1985","unstructured":"Cheney BV, Szmuszkovicz J, Lahti RA, Zichi DA (1985) Factors affecting binding of trans-N-[2-(methylamino)cyclohexyl]benzamides at the primary morphine receptor. J Med Chem 28:1853\u20131864","journal-title":"J Med Chem"},{"key":"1969_CR8","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.neuropharm.2017.08.016","volume":"134","author":"MH Baumann","year":"2017","unstructured":"Baumann MH, Majumdar S, Le Rouzic V, Hunkele A, Uprety R, Huang XP, Xu J, Roth BL, Pan YX, Pasternak GW (2017) Pharmacological characterization of novel synthetic opioids (NSO) found in the recreational drug marketplace. Neuropharmacology 134:101\u2013107. \n                    https:\/\/doi.org\/10.1016\/j.neuropharm.2017.08.016","journal-title":"Neuropharmacology"},{"issue":"1","key":"1969_CR9","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s11419-016-0347-4","volume":"35","author":"P Nikolaou","year":"2017","unstructured":"Nikolaou P, Katselou M, Papoutsis I, Spiliopoulou C, Athanaselis S (2017) U-47700. An old opioid becomes a recent danger. Forensic Toxicol 35(1):11\u201319. \n                    https:\/\/doi.org\/10.1007\/s11419-016-0347-4","journal-title":"Forensic Toxicol"},{"key":"1969_CR10","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.toxac.2017.07.004","volume":"30","author":"V Coopman","year":"2017","unstructured":"Coopman V, Cordonnier J (2017) \u2018Spice-like\u2019 herbal incense laced with the synthetic opioid U-47700. Toxicol Anal Clin 30:75\u201379. \n                    https:\/\/doi.org\/10.1016\/j.toxac.2017.07.004","journal-title":"Toxicol Anal Clin"},{"key":"1969_CR11","unstructured":"U-47700 Critical Review Report Agenda Item 4.1 Expert Committee on Drug Dependence Thirty-eighth Meeting Geneva, 14\u201318 November 2016 Available from \n                    http:\/\/www.who.int\/medicines\/access\/controlled-substances\/4.1_U-47700_CritReview.pdf"},{"key":"1969_CR12","unstructured":"DEA Headquarters News. (2016) DEA schedules deadly synthetic drug U-47700. Drug Enforcement Administration. Washington D.C. https:\/\/ \n                    www.dea.gov\/divisions\/hq\/2016\/hq111016.shtml\n                    \n                   (accessed November 17, 2017)"},{"issue":"1","key":"1969_CR13","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1080\/15563650.2016.1209767","volume":"55","author":"MJ Jones","year":"2017","unstructured":"Jones MJ, Hernandez BS, Janis GC, Stellpflug SJ (2017) A case of U-47700 overdose with laboratory confirmation and metabolite identification. Clin Toxicol (Phila) 55(1):55\u201359. \n                    https:\/\/doi.org\/10.1080\/15563650.2016.1209767","journal-title":"Clin Toxicol (Phila)"},{"issue":"3","key":"1969_CR14","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s12024-016-9795-8","volume":"12","author":"X Ruan","year":"2016","unstructured":"Ruan X, Chiravuri S, Kaye AD (2016) Comparing fatal cases involving U-47700. Forensic Sci Med Pathol 12(3):369\u2013371. \n                    https:\/\/doi.org\/10.1007\/s12024-016-9795-8","journal-title":"Forensic Sci Med Pathol"},{"issue":"219","key":"1969_CR15","first-page":"79389","volume":"81","author":"Drug Enforcement Administration, Department of Justice","year":"2016","unstructured":"Drug Enforcement Administration, Department of Justice (2016) Schedules of Controlled Substances: Temporary Placement of U-47700 Into Schedule I. Final Order Fed Regist 81(219):79389\u201379393","journal-title":"Final Order Fed Regist"},{"issue":"8","key":"1969_CR16","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1002\/dta.1984","volume":"8","author":"SP Elliott","year":"2016","unstructured":"Elliott SP, Brandt SD, Smith C (2016) The first reported fatality associated with the synthetic opioid 3,4-dichloro-N-[2-(dimethylamino) cyclohexyl]-N-methylbenzamide (U47700) and implications for forensic analysis. Drug Test Anal 8(8):875\u2013879. \n                    https:\/\/doi.org\/10.1002\/dta.1984","journal-title":"Drug Test Anal"},{"key":"1969_CR17","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.forsciint.2016.05.001","volume":"266","author":"V Coopman","year":"2016","unstructured":"Coopman V, Blanckaert P, Van Parys G, Van Calenbergh S, Cordonnier J (2016) A case of acute intoxication due to combined use of fentanyl and 3,4-dichloro-N-[2 (dimethylamino)cyclohexyl]-N-methylbenzamide (U-47700). Forensic Sci Int 266:68\u201372. \n                    https:\/\/doi.org\/10.1016\/j.forsciint.2016.05.001","journal-title":"Forensic Sci Int"},{"issue":"6","key":"1969_CR18","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1007\/s00414-017-1593-7","volume":"131","author":"M Dziadosz","year":"2017","unstructured":"Dziadosz M, Klintschar M, Teske J (2017) Postmortem concentration distribution in fatal cases involving the synthetic opioid U-47700. Int J Legal Med 131(6):1555\u20131556. \n                    https:\/\/doi.org\/10.1007\/s00414-017-1593-7","journal-title":"Int J Legal Med"},{"key":"1969_CR19","unstructured":"Kriikku P. Novel psychoactive substances in postmortem toxicology, \n                    http:\/\/emcdda.europa.eu\/system\/files\/attachments\/3233\/Kriikku_NPS%20in%20postmortem%20investigations.pdf_en\n                    \n                   (accessed december 6 2017)"},{"key":"1969_CR20","doi-asserted-by":"publisher","first-page":"S60","DOI":"10.1016\/j.toxac.2017.03.087","volume":"29","author":"TV Bui","year":"2017","unstructured":"Bui TV, Batisse A, Marillier M, Bourgogne E, Djezzar S, Megarbane B (2017) L\u2019arriv\u00e9e des opio\u00efdes de synth\u00e8se en France, un signal d\u2019addictovigilance \u00e0 surveiller : illustration par un cas clinique. Toxac 29:S60\u2013S61. \n                    https:\/\/doi.org\/10.1016\/j.toxac.2017.03.087","journal-title":"Toxac"},{"key":"1969_CR21","unstructured":"UNODC (2017) World Drug Report 2017 (ISBN: 978\u201392\u20131-148291-1, eISBN: 978\u201392\u20131-060623-3, United Nations publication, Sales No. E.17.XI.6)"},{"key":"1969_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.toxac.2017.07.002","volume":"30","author":"SFTA guidelines for the achievement of toxicological analyzes for deaths involving NPS","year":"2018","unstructured":"SFTA guidelines for the achievement of toxicological analyzes for deaths involving NPS (2018) Recommandations de la SFTA pour la r\u00e9alisation des analyses toxicologiques dans les cas de d\u00e9c\u00e8s impliquant des NPS. Toxicol Anal Clin 30:1\u20134. \n                    https:\/\/doi.org\/10.1016\/j.toxac.2017.07.002","journal-title":"Toxicol Anal Clin"},{"key":"1969_CR23","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1007\/s00216-013-7574-x","volume":"406","author":"R Kronstrand","year":"2014","unstructured":"Kronstrand R, Brinkhagen L, Birath-Karlsson C, Roman M, Josefsson M (2014) LC-QTOF-MS as a superior strategy to immunoassay for the comprehensive analysis of synthetic cannabinoids in urine. Anal Bioanal Chem 406:3599\u20133609","journal-title":"Anal Bioanal Chem"},{"issue":"4","key":"1969_CR24","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1208\/s12248-017-0070-z","volume":"19","author":"S Watanabe","year":"2107","unstructured":"Watanabe S, Vikingsson S, Roman M, Green H, Kronstrand R, Wohlfarth A (2107) In vitro and in vivo metabolite identification studies for the new synthetic opioids acetylfentanyl, acrylfentanyl, furanylfentanyl, and 4-fluoro-isobutyrylfentanyl. AAPS J 19(4):1102\u20131122. \n                    https:\/\/doi.org\/10.1208\/s12248-017-0070-z","journal-title":"AAPS J"},{"issue":"6","key":"1969_CR25","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1002\/dta.2326","volume":"10","author":"N Allibe","year":"2018","unstructured":"Allibe N, Richeval C, Phanithavong M, Faure A, Allorge D, Paysant F, Stanke-Labesque F, Eysseric-Guerin H, Gaulier JM (2018) Fatality involving ocfentanil documented by identification of metabolites. Drug Test Anal 10(6):995\u20131000. \n                    https:\/\/doi.org\/10.1002\/dta.2326","journal-title":"Drug Test Anal"},{"issue":"10","key":"1969_CR26","doi-asserted-by":"publisher","first-page":"806","DOI":"10.2174\/1389201018666171122124401","volume":"18","author":"C Richeval","year":"2017","unstructured":"Richeval C, Gicquel T, Hugbart C, Le Dare B, Allorge D, Morel I, Gaulier JM (2017) In vitro characterization of NPS metabolites produced by human liver microsomes and the HepaRG cell line using liquid chromatography-high resolution mass spectrometry (LC-HRMS) analysis: application to furanyl fentanyl. Curr Pharm Biotechnol 18(10):806\u2013814. \n                    https:\/\/doi.org\/10.2174\/1389201018666171122124401","journal-title":"Curr Pharm Biotechnol"},{"issue":"3","key":"1969_CR27","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1093\/jat\/bkw131","volume":"41","author":"SW Fleming","year":"2017","unstructured":"Fleming SW, Cooley JC, Johnson L, Frazee CC, Domanski K, Kleinschmidt K, Garg U (2017) Analysis of U-47700, a novel synthetic opioid, in human urine by LC-MS-MS and LC-QToF. J Anal Toxicol 41(3):173\u2013180. \n                    https:\/\/doi.org\/10.1093\/jat\/bkw131","journal-title":"J Anal Toxicol"},{"issue":"6","key":"1969_CR28","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1093\/jat\/bkx049","volume":"41","author":"J Seither","year":"2017","unstructured":"Seither J, Reidy L (2017) Confirmation of Carfentanil, U-47700 and other synthetic opioids in a human performance case by LC-MS-MS. J Anal Toxicol 41(6):493\u2013497. \n                    https:\/\/doi.org\/10.1093\/jat\/bkx049","journal-title":"J Anal Toxicol"},{"issue":"1","key":"1969_CR29","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1002\/dta.2228","volume":"10","author":"AJ Krotulski","year":"2018","unstructured":"Krotulski AJ, Mohr ALA, Papsun DM, Logan BK (2018) Metabolism of novel opioid agonists U-47700 and U-49900 using human liver microsomes with confirmation in authentic urine specimens from drug users. Drug Test Anal 10(1):127\u2013136","journal-title":"Drug Test Anal"},{"issue":"1","key":"1969_CR30","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1111\/j.1556-4029.2012.02254.x","volume":"58","author":"YP Gaillard","year":"2013","unstructured":"Gaillard YP, Cuquel AC, Boucher A, Romeuf L, Bevalot F, Prevosto JM, Menard JM (2013) A fatality following ingestion of the designer drug meta-chlorophenylpiperazine (mCPP) in an asthmatic\u2014HPLC-MS\/MS detection in biofluids and hair. J Forensic Sci 58(1):263\u2013269. \n                    https:\/\/doi.org\/10.1111\/j.1556-4029.2012.02254.x","journal-title":"J Forensic Sci"},{"issue":"6","key":"1969_CR31","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1111\/1556-4029.12250","volume":"58","author":"C Mazoyer","year":"2013","unstructured":"Mazoyer C, Carlier J, Boucher A, P\u00e9oc'h M, Lemeur C, Gaillard Y (2013) Fatal case of a 27-year-old male after taking iboga in withdrawal treatment: GC-MS\/MS determination of ibogaine and ibogamine in iboga roots and postmortem biological material. J Forensic Sci 58(6):1666\u20131672. \n                    https:\/\/doi.org\/10.1111\/1556-4029.12250","journal-title":"J Forensic Sci"},{"key":"1969_CR32","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jchromb.2014.10.028","volume":"975","author":"J Carlier","year":"2015","unstructured":"Carlier J, Guitton J, Romeuf L, B\u00e9valot F, Boyer B, Fanton L, Gaillard Y (2015) Screening approach by ultra-high performance liquid chromatography-tandem mass spectrometry for the blood quantification of thirty-four toxic principles of plant origin. Application to forensic toxicology. J Chromatogr B Anal Technol Biomed Life Sci 975:65\u201376. \n                    https:\/\/doi.org\/10.1016\/j.jchromb.2014.10.028","journal-title":"J Chromatogr B Anal Technol Biomed Life Sci"},{"issue":"2\u20133","key":"1969_CR33","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.forsciint.2006.05.021","volume":"165","author":"FT Peters","year":"2007","unstructured":"Peters FT, Drummer OH, Musshoff F (2007) Validation of new methods. Forensic Sci Int 165(2\u20133):216\u2013224. \n                    https:\/\/doi.org\/10.1016\/j.forsciint.2006.05.021","journal-title":"Forensic Sci Int"},{"key":"1969_CR34","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s00769-011-0775-0","volume":"16","author":"SMR Wille","year":"2011","unstructured":"Wille SMR, Peters FT, Di Fazio V, Samyn N (2011) Practical aspects concerning validation and quality control for forensic and clinical bioanalytical quantitative methods. Accred Qual Assur 16:279\u2013292. \n                    https:\/\/doi.org\/10.1007\/s00769-011-0775-0","journal-title":"Accred Qual Assur"},{"key":"1969_CR35","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1208\/s12248-016-9963-5","volume":"18","author":"MG Feasel","year":"2016","unstructured":"Feasel MG, Wohlfarth A, Nilles JM, Pang S, Kristovich RL, Huestis MA (2016) Metabolism of Carfentanil, an ultra-potent opioid, in human liver microsomes and human hepatocytes by high-resolution mass spectrometry. AAPS J 18:1489\u20131499. \n                    https:\/\/doi.org\/10.1208\/s12248-016-9963-5","journal-title":"AAPS J"},{"key":"1969_CR36","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1007\/s00216-011-5528-8","volume":"402","author":"MR Meyer","year":"2012","unstructured":"Meyer MR, Dinger J, Schwaninger AE, Wissenbach DK, Zapp J, Fritschi G, Maurer HH (2012) Qualitative studies on the metabolism and the toxicological detection of the fentanyl-derived designer drugs 3-methylfentanyl and isofentanyl in rats using liquid chromatography-linear ion trap-mass spectrometry (LC-MS(n)). Anal Bioanal Chem 402:1249\u20131255. \n                    https:\/\/doi.org\/10.1007\/s00216-011-5528-8","journal-title":"Anal Bioanal Chem"},{"issue":"7","key":"1969_CR37","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1002\/dta.2111","volume":"9","author":"AE Steuer","year":"2017","unstructured":"Steuer AE, Williner E, Staeheli SN, Kraemer T (2017) Studies on the metabolism of the fentanyl-derived designer drug butyrfentanyl in human in vitro liver preparations and authentic human samples using liquid chromatography-high resolution mass spectrometry (LC-HRMS). Drug Test Anal 9(7):1085\u20131092","journal-title":"Drug Test Anal"},{"issue":"4","key":"1969_CR38","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1002\/dta.1507","volume":"6","author":"T Launiainen","year":"2014","unstructured":"Launiainen T, Ojanper\u00e4 I (2014) Drug concentrations in post-mortem femoral blood compared with therapeutic concentrations in plasma. Drug Test Anal 6(4):308\u2013316. \n                    https:\/\/doi.org\/10.1002\/dta.1507","journal-title":"Drug Test Anal"},{"key":"1969_CR39","unstructured":"Seeger E. Pykrolidino ketones. Patent US; 1967\/3314970 A"},{"issue":"2","key":"1969_CR40","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1007\/s11419-014-0238-5","volume":"32","author":"N Uchiyama","year":"2014","unstructured":"Uchiyama N, Shimokawa Y, Kawamura M, Kikura-Hanajiri R, Hakamatsuka T (2014) Chemical analysis of a benzofuran derivative, 2-(2-ethylaminopropyl)benzofuran (2-EAPB), eight synthetic cannabinoids, five cathinone derivatives, and five other designer drugs newly detected in illegal products. Forensic Toxicol 32(2):266\u2013281. \n                    https:\/\/doi.org\/10.1007\/s11419-014-0238-5","journal-title":"Forensic Toxicol"},{"issue":"11","key":"1969_CR41","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1002\/jms.3642","volume":"50","author":"M Paul","year":"2015","unstructured":"Paul M, Bleicher S, Guber S, Ippisch J, Polettini A, Schultis W (2015) Identification of phase I and II metabolites of the new designer drug \u03b1-pyrrolidinohexiophenone (\u03b1-PHP) in human urine by liquid chromatography quadrupole time-of-flight mass spectrometry (LC-QTOF-MS). J Mass Spectrom 50(11):1305\u20131317. \n                    https:\/\/doi.org\/10.1002\/jms.3642\n                    \n                   Erratum in: J Mass Spectrom 2016 51(4):322","journal-title":"J Mass Spectrom"},{"key":"1969_CR42","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1002\/dta.2355","volume":"10","author":"SK Manier","year":"2018","unstructured":"Manier SK, Richter LHJ, Sch\u00e4per J, Maurer HH, Meyer MR (2018) Different in vitro and in vivo tools for elucidating the human metabolism of alpha-cathinone-derived drugs of abuse. Drug Test Anal 10:1119\u20131130. \n                    https:\/\/doi.org\/10.1002\/dta.2355","journal-title":"Drug Test Anal"},{"key":"1969_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jat\/bkx080","volume":"28","author":"Y Fujita","year":"2017","unstructured":"Fujita Y, Mita T, Usui K, Kamijo Y, Kikuchi S, Onodera M, Fujino Y, Inoue Y (2017) Toxicokinetics of the synthetic cathinone \u03b1-pyrrolidinohexanophenone. J Anal Toxicol 28:1\u20135. \n                    https:\/\/doi.org\/10.1093\/jat\/bkx080","journal-title":"J Anal Toxicol"},{"issue":"2s","key":"1969_CR44","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.toxac.2017.03.019","volume":"29","author":"M Nachon-Phanithavong","year":"2017","unstructured":"Nachon-Phanithavong M, Richeval C, Gaulier JM, Humbert L, Tournebize J, Kieffer P, Allorge D (2017) Intoxication aigu\u00eb et consommation chronique de cathinones chez un polyconsommateur. Toxac 29(2s):22. \n                    https:\/\/doi.org\/10.1016\/j.toxac.2017.03.019","journal-title":"Toxac"},{"key":"1969_CR45","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.neuropharm.2014.02.016","volume":"87","author":"JA Marusich","year":"2014","unstructured":"Marusich JA, Antonazzo KR, Wiley JL, Blough BE, Partilla JS, Baumann MH (2014) Pharmacology of novel synthetic stimulants structurally related to the \u201cbath salts\u201d constituent 3,4-methylenedioxypyrovalerone (MDPV). Neuropharmacology 87:206\u2013213. \n                    https:\/\/doi.org\/10.1016\/j.neuropharm.2014.02.016","journal-title":"Neuropharmacology"},{"issue":"4","key":"1969_CR46","first-page":"11","volume":"40","author":"SA Short","year":"2016","unstructured":"Short SA, Schultz J, Lawler E, Wells K (2016) Postmortem cases involving fentanyl derivatives and U-47700. Toxtalk 40(4):11\u201313","journal-title":"Toxtalk"},{"issue":"2","key":"1969_CR47","first-page":"158","volume":"41","author":"IM McIntyre","year":"2017","unstructured":"McIntyre IM, Gary RD, Joseph S, Stabbley R (2017) A fatality related to the synthetic opioid U-47700: postmortem concentration distribution. J Anal Toxicol 41(2):158\u2013160","journal-title":"J Anal Toxicol"},{"key":"1969_CR48","doi-asserted-by":"publisher","unstructured":"Kapil RP, Friedman K, Cipriano A, Michels G, Shet M, Mondal SA, Harris SC (2015) Effects of paroxetine, a CYP2D6 inhibitor, on the pharmacokinetic properties of hydrocodone after coadministration with a single-entity, once-daily, extended-release hydrocodone tablet. Clin Ther 37(10):2286\u20132296. \n                    https:\/\/doi.org\/10.1016\/j.clinthera.2015.08.007","DOI":"10.1016\/j.clinthera.2015.08.007"},{"key":"1969_CR49","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.2147\/JPR.S138698","volume":"10","author":"XQ Feng","year":"2017","unstructured":"Feng XQ, Zhu LL, Zhou Q (2017) Opioid analgesics-related pharmacokinetic drug interactions: from the perspectives of evidence based on randomized controlled trials and clinical risk management. J Pain Res 10:1225\u20131239. \n                    https:\/\/doi.org\/10.2147\/JPR.S138698","journal-title":"J Pain Res"},{"issue":"4","key":"1969_CR50","doi-asserted-by":"publisher","first-page":"R136","DOI":"10.1186\/cc11441","volume":"16","author":"M Schulz","year":"2012","unstructured":"Schulz M, Iwersen-Bergmann S, Andresen H, Schmoldt A (2012) Therapeutic and toxic blood concentrations of nearly 1,000 drugs and other xenobiotics. Crit Care 16(4):R136. \n                    https:\/\/doi.org\/10.1186\/cc11441","journal-title":"Crit Care"}],"container-title":["International Journal of Legal Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00414-018-1969-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00414-018-1969-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00414-018-1969-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,14]],"date-time":"2019-11-14T19:17:12Z","timestamp":1573759032000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00414-018-1969-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,15]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["1969"],"URL":"https:\/\/doi.org\/10.1007\/s00414-018-1969-3","relation":{},"ISSN":["0937-9827","1437-1596"],"issn-type":[{"value":"0937-9827","type":"print"},{"value":"1437-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,15]]},"assertion":[{"value":"27 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}